2023 PCE Oncology Fall Conferences – Evening of Hematology

PCE, the national leader in continuing education for NPs and PAs, presents the 2023 PCE Oncology Fall Conference – Evening of Hematology. This complimentary CE/CME meeting is tailored to meet the clinical needs and evolving scope of practice of NPs, PAs, and nurses who practice in oncology. Review the latest evidence-based strategies for contemporary care of your patients with CLL/SLL and MCL, DLBCL, and multiple myeloma with downloadable slides from CCO and PCE. 

Share

Program Content

Activities

Managing CLL and MCL With BTKi
Current and Emerging Roles of BTK Inhibitors in CLL/SLL and MCL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 13, 2023

View Activity
BTK Inhibitors in Blood Cancer
Current and Emerging Roles of BTK Inhibitors in CLL/SLL and MCL
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2023

Expires: December 11, 2024

View Activity
BTKi in CLL/SLL and MCL
BTK Inhibitors in CLL/SLL and MCL: The Latest Guidance and Evidence for the Clinic
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 14, 2023

View Activity

Activities

CD38 Antibodies in MM
Recent Progress With CD38 Antibodies to Improve Outcomes in Multiple Myeloma: Expert Guidance for Clinical Practice
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 09, 2023

View Activity

Activities

R/R DLBCL
Therapeutic Advances in Relapsed/Refractory DLBCL: Improving Outcomes with Novel Approaches to Targeted Therapy
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2023

View Activity

Faculty

cover img faculity

John N. Allan, MD

Associate Professor of Clinical Medicine
Division of Hematology and Medical Oncology
Weill Cornell Medicine
New York, New York

cover img faculity

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

cover img faculity

Ajai Chari, MD

Director of Multiple Myeloma Program
Professor of Clinical Medicine
University of California- San Francisco
San Francisco, California

cover img faculity

Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio

cover img faculity

Saad Z. Usmani, MD, MBA, FACP

Chief of Myeloma Service
Memorial Sloan Kettering Cancer Center
Professor
Weill Cornell Medical College, Cornell University
New York, New York

Provided by

ProCE Banner
ProCE Banner
ProCE Banner
ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) and Clinical Care Options, LLC

Supporters

Recent Progress With CD38 Antibodies to Improve Outcomes in Multiple Myeloma: Expert Guidance for Clinical Practice
Supported by an educational grant from Sanofi.

Current and Emerging Roles of BTK Inhibitors in CLL/SLL and MCL
Supported by an educational grant from Merck Sharp & Dohme LLC.

Therapeutic Advances in Relapsed/Refractory DLBCL: Improving Outcomes With Novel Approaches to Targeted Therapy
Supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Merck Sharp & Dohme, LLC

Regeneron Pharmaceuticals, Inc

Sanofi